Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liberty Dialysis is a prominent provider of dialysis services specializing in the treatment of end-stage renal disease and chronic kidney failure. Established in 2002, the company grew significantly by partnering with local nephrologists to develop and manage dialysis clinics across the United States, including a notable presence in Alaska under the Denali Dialysis brand. In 2012, Liberty Dialysis was acquired by Fresenius Medical Care for approximately $1.7 billion, integrating its extensive network into the world's largest dialysis care system. The organization provides a range of services including in-center hemodialysis, home hemodialysis, and peritoneal dialysis. Its business model emphasizes clinical quality and physician-led care to improve patient outcomes in the renal care space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liberty & Denali Dialysis.